GLS Capital Principals Recognized in 2024 IAM Strategy 300 Global Leaders

GLS Capital, one of the world’s largest private investment firms focused on litigation finance, announced that firm co-founders and Managing Directors Adam Gill and Jamison Lynch, and firm Principal Joel Merkin have been recognized in the 2024 edition of IAM Strategy 300 Global Leaders.

GLS Capital Managing Director Adam Gill shared the following regarding the recognition:

“GLS Capital is grateful for IAM’s recognition of our team’s expertise and success in intellectual property transactions and disputes.  We are also especially grateful to the law firms and patent owners that choose GLS to partner with.”

The only resource of its kind in the IP world, IAM Strategy 300 Global Leaders showcases the top IP professionals in North America, Europe, and Asia, including leaders from across in-house, private practice, and service provider roles. IAM (Intellectual Asset Management magazine) is a leading source of worldwide news, analysis, and data on the management of intellectual property as a key business asset.

Gill is a founder and Managing Director of GLS Capital, where he leads all patent investments. Prior to co-founding GLS Capital, he led patent investment teams at two of the world’s largest litigation finance providers. Prior to working in litigation finance, he was a partner in the patent litigation group at Kirkland & Ellis LLP in Chicago.

Lynch is also a co-founder of GLS Capital and leads its investments in life sciences and special situations, including matters involving product development, regulatory approval, and litigation regarding medical devices, pharmaceutical products, health care, and other life sciences matters. Previously, he was a principal at two of the world’s largest litigation finance firms, where he led life sciences investments, including those involving patent litigation. He also formerly co-led the global patent litigation team at Gilead Sciences, Inc. and was a partner at Mayer Brown, where he was actively involved in pharmaceutical patent litigation, patent prosecution, and due diligence in the firm’s Chicago and Frankfurt offices.

Merkin is a Principal at GLS Capital and is responsible for due diligence and monitoring of patent investments. Merkin is a registered patent attorney and uses his patent litigation experience and engineering background to evaluate patent opportunities, particularly in the high-tech space. He has worked with patents involving a wide range of technologies, including computer hardware and software, communication systems, consumer electronics, and medical devices. He has significant experience in all phases of patent litigation, including his previous work as a partner in the intellectual property litigation group at Kirkland & Ellis LLP in Chicago. He has deep experience with complex patent litigation before federal district courts, the Patent Trial and Appeal Board, the International Trade Commission, and the Federal Circuit. Merkin earned his J.D. from the University of Illinois College of Law and a Bachelor of Science from the University of Illinois Urbana-Champaign.

Skip to content